Eledon Pharmaceuticals, Inc. (ELDN)
3.465
+0.06
(+1.61%)
USD |
NASDAQ |
Aug 25, 09:55
Eledon Pharmaceuticals Debt to Equity Ratio : 0.0065 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0065 |
| March 31, 2026 | 0.0055 |
| December 31, 2025 | 0.0047 |
| September 30, 2025 | 0.0079 |
| June 30, 2025 | 0.0076 |
| March 31, 2025 | 0.0077 |
| December 31, 2024 | 0.0081 |
| September 30, 2024 | 0.0066 |
| June 30, 2024 | -0.077 |
| March 31, 2024 | -0.0193 |
| December 31, 2023 | 0.0531 |
| September 30, 2023 | 0.0052 |
| June 30, 2023 | 0.0057 |
| March 31, 2023 | 0.0089 |
| December 31, 2022 | 0.0089 |
| September 30, 2022 | 0.0059 |
| June 30, 2022 | 0.0039 |
| March 31, 2022 | 0.0043 |
| December 31, 2021 | 0.0047 |
| September 30, 2021 | 0.0013 |
| June 30, 2021 | 0.0015 |
| March 31, 2021 | 0.0005 |
| December 31, 2020 | 0.0008 |
| September 30, 2020 | 7.679 |
| June 30, 2020 | 0.0252 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0239 |
| December 31, 2019 | 0.0342 |
| September 30, 2019 | 0.0275 |
| June 30, 2019 | 0.0255 |
| March 31, 2019 | 0.0454 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -1.276 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Viking Therapeutics, Inc. | 0.01 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 126.09M |
| Total Liabilities (Quarterly) | 54.06M |
| Shareholders Equity (Quarterly) | 72.03M |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 0.03% |